European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Mark Lawler(Queen's University Belfast), Richard Sullivan(King's College London), Jacek Jassem, Lynne Davies(World Cancer Research Fund International), Maja Južnič Sotlar, Daniel Kelly(Cardiff University), Kathy Oliver(European CanCer Organisation), Marius Geantă, Teodora Kolarova, Olaf Kelm(Centre International de Recherche sur le Cancer), Beata Jagielska(The Maria Sklodowska-Curie National Research Institute of Oncology), Kathi Apostolidis(European CanCer Organisation), Yolande Lievens(Ghent University Hospital), Mirjam Crul(Amsterdam University Medical Centers), Fátima Cardoso(Université Paris Cité), Matti Aapro(Breast Center), Ajay Aggarwal(London School of Hygiene & Tropical Medicine), Csaba László Dégi(Babeș-Bolyai University), Isabel T. Rubio(Clinica Universidad de Navarra), Urszula Wojciechowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Sema Erdem(European CanCer Organisation), Jolanda C. van Hoeve(Netherlands Comprehensive Cancer Organisation), Bengt Jönsson(Stockholm School of Economics), Michel P. Coleman(University of London), Grant Lewison(Guy's Hospital), Alexander M.M. Eggermont(Institut Gustave Roussy), Andreas Charalambous(University of Turku), Jan Geißler, Anna Schmutz(Centre International de Recherche sur le Cancer), Tanja Čufer(University of Ljubljana), Peter Naredi(European CanCer Organisation), Jana Pelouchová, Tezer Kutluk(Hacettepe University), Anne‐Marie Baird(Trinity College Dublin), Willien Westerhuis(Organisation of European Cancer Institutes), Carlo La Vecchia(University of Milan), Simon Oberst(Cancer Research UK), Beate Rau(Charité - Universitätsmedizin Berlin), Peter J. Selby(Blood Cancer UK), Gilliosa Spurrier‐Bernard, Richard Price(European CanCer Organisation), Eduard Vrdoljak(University of Split), Thierry Philip(Institut Curie), Alberto Costa(European School of Oncology), Claudia Allemani(London School of Hygiene & Tropical Medicine), Françoise Meunier, Federica Di Nicolantonio(IFOM)
Cited by 104
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k